---
title: Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients
  with High-Risk Myeloid Malignancies
date: '2024-02-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38339283/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240210170637&v=2.18.0
source: heidelberg[Affiliation]
description: Up to 50% of patients with high-risk myeloid malignancies die of relapse
  after allogeneic stem cell transplantation. Current sequential conditioning regimens
  like the FLAMSA protocol combine intensive induction therapy with TBI or alkylators.
  Venetoclax has synergistic effects to chemotherapy. In a retrospective survey among
  German transplant centers, we identified 61 patients with myeloid malignancies that
  had received FLAMSA-based sequential conditioning with venetoclax between 2018 and
  ...
disable_comments: true
---
Up to 50% of patients with high-risk myeloid malignancies die of relapse after allogeneic stem cell transplantation. Current sequential conditioning regimens like the FLAMSA protocol combine intensive induction therapy with TBI or alkylators. Venetoclax has synergistic effects to chemotherapy. In a retrospective survey among German transplant centers, we identified 61 patients with myeloid malignancies that had received FLAMSA-based sequential conditioning with venetoclax between 2018 and ...